Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (728 total)
-
Creator: NETEC
Subject: Infection Control
Item Type: Guide
Date Last Updated: 2022-03-16
Description: This printable flyer infographic "Mind the Gap! Facemask Fit Matters" contains information on mask and masks fit, fitting masks, as maximum mask-to-skin contact is essential.Mind the Gap:Mask Filtration and Fit Matter:Mind the Gap!No matter how well… -
Creator: NETEC
Subject: Infection Control
Item Type: Webinar
Date Last Updated: 2022-01-14
Description: Join us Friday, January 14th, at 12pm CST for the NETEC COVID-19 Webinar Series presentation, Respiratory Protection Program (RPP) for the Non-Acute Healthcare Providers. Topics will include OSHA standards for an effective respiratory protection… -
Creator: NETEC
Subject: Infection Control
Item Type: Guide
Date Last Updated: 2022-01-07
Description: The treatment and infection prevention recommendations for influenza and COVID-19 are VERY different. It is important to test and differentiate. This two page graphic provides guidance. -
Creator: CDC
Subject: Emergency Management
Item Type: Guide
Date Last Updated: 2021-09-16
Description: Audience: These considerations are intended for use by federal, state, and local public health officials, respiratory protection program managers, leaders in occupational health services and infection prevention and control programs, and other…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Creator: CDC
Subject: Emergency Management
Item Type: Guide
Date Last Updated: 2020-10-19
Description: The CDC flowchart attached to this page guides you through determining if an N95 FFR Crisis Capacity strategy is needed.Implementing Filtering Facepiece Respirator (FFR) Reuse, Including Reuse after Decontamination, When There Are Known Shortages of…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Creator: NETEC
Subject: Emergency Management
Item Type: Webinar
Date Last Updated: 2021-11-12
Description: Join us Friday, November 12th, at 12pm CST for the next NETEC COVID-19 Webinar Series presentation, Influenza in the Age of COVID: 2021 Seasonal Update. Join our presenters as they discuss important topics surrounding the upcoming 2021 influenza… -
Creator: Mumma, J. M., E. Jordan, O. Ayeni, N. Kaufman, M. J. Wheatley, A. Grindle, and J. Morgan. 2021.
Subject: Infection Control
Item Type: Publication
Date Last Updated: 2021-10-20
Description: During the COVID-19 pandemic, the use of face masks by the public has helped to slow the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the community. Cloth masks have been recommended because of their effectiveness,… -
Creator: Li, L., L. B. Robinson, R. Patel, A. B. Landman, X. Fu, E. S. Shenoy, D. M. Hashimoto, A. Banerji, P. G. Wickner, U. Samarakoon, C. M. Mancini, Y. Zhang, and K. G. Blumenthal.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-10-01
Description: Allergic history in individuals with confirmed anaphylaxis to a messenger RNA (mRNA) COVID-19 vaccine is common. However, the risk factors for allergy symptoms after receiving the vaccine are unknown. -
Creator: Bar-On, Yinon M., Yair Goldberg, Micha Mandel, Omri Bodenheimer, Laurence Freedman, Nir Kalkstein, Barak Mizrahi, Sharon Alroy-Preis, Nachman Ash, Ron Milo, and Amit Huppert.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-10-07
Description: On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at least 5… -
Creator: the BLAZE-1 Investigators
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-10-07
Description: Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and…